Uniqure NVNASDAQ:QURE
- LAST PRICE4.5400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.3600/ 1
- Ask / Lots5.0000/ 10
- Open / Previous Close--- / 4.5400
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | QURE |
|---|---|---|
| 09:32 ET | 7603 | 4.523 |
| 09:34 ET | 4772 | 4.5251 |
| 09:36 ET | 3943 | 4.555 |
| 09:38 ET | 100 | 4.555 |
| 09:39 ET | 1730 | 4.55 |
| 09:43 ET | 1664 | 4.533 |
| 09:45 ET | 500 | 4.52 |
| 09:48 ET | 100 | 4.53 |
| 09:50 ET | 1200 | 4.54 |
| 09:52 ET | 700 | 4.53 |
| 09:54 ET | 320 | 4.5382 |
| 09:56 ET | 2014 | 4.53 |
| 09:57 ET | 430 | 4.53 |
| 09:59 ET | 200 | 4.53 |
| 10:01 ET | 1303 | 4.5235 |
| 10:03 ET | 6483 | 4.52 |
| 10:06 ET | 8119 | 4.5537 |
| 10:08 ET | 5500 | 4.53 |
| 10:12 ET | 2400 | 4.54 |
| 10:14 ET | 1100 | 4.55 |
| 10:15 ET | 7497 | 4.58 |
| 10:17 ET | 210 | 4.5684 |
| 10:19 ET | 903 | 4.57 |
| 10:21 ET | 300 | 4.57 |
| 10:24 ET | 285 | 4.57 |
| 10:26 ET | 400 | 4.56 |
| 10:28 ET | 1219 | 4.56 |
| 10:30 ET | 100 | 4.56 |
| 10:32 ET | 1000 | 4.55 |
| 10:33 ET | 475 | 4.57 |
| 10:35 ET | 2078 | 4.57 |
| 10:37 ET | 519 | 4.57 |
| 10:39 ET | 566 | 4.57 |
| 10:42 ET | 14128 | 4.57 |
| 10:44 ET | 3016 | 4.58 |
| 10:46 ET | 5636 | 4.61 |
| 10:48 ET | 25321 | 4.595 |
| 10:50 ET | 4420 | 4.6 |
| 10:51 ET | 310 | 4.625 |
| 10:53 ET | 15087 | 4.6299 |
| 10:55 ET | 1300 | 4.615 |
| 10:57 ET | 1000 | 4.6252 |
| 11:00 ET | 600 | 4.615 |
| 11:02 ET | 8400 | 4.6201 |
| 11:04 ET | 6000 | 4.6201 |
| 11:06 ET | 1502 | 4.64 |
| 11:08 ET | 2867 | 4.62 |
| 11:09 ET | 100 | 4.6107 |
| 11:11 ET | 817 | 4.59 |
| 11:15 ET | 100 | 4.58 |
| 11:18 ET | 100 | 4.58 |
| 11:20 ET | 320 | 4.58 |
| 11:24 ET | 500 | 4.565 |
| 11:26 ET | 100 | 4.55 |
| 11:33 ET | 5799 | 4.54 |
| 11:38 ET | 600 | 4.55 |
| 11:40 ET | 500 | 4.56 |
| 11:42 ET | 1100 | 4.56 |
| 11:44 ET | 400 | 4.57 |
| 11:45 ET | 100 | 4.57 |
| 11:47 ET | 1202 | 4.57 |
| 11:49 ET | 2095 | 4.575 |
| 11:54 ET | 1900 | 4.57 |
| 11:56 ET | 600 | 4.57 |
| 12:02 ET | 1200 | 4.55 |
| 12:05 ET | 300 | 4.555 |
| 12:07 ET | 700 | 4.555 |
| 12:09 ET | 618 | 4.56 |
| 12:12 ET | 600 | 4.56 |
| 12:14 ET | 832 | 4.56 |
| 12:16 ET | 22976 | 4.58 |
| 12:18 ET | 1900 | 4.57 |
| 12:20 ET | 12337 | 4.575 |
| 12:21 ET | 200 | 4.575 |
| 12:23 ET | 300 | 4.575 |
| 12:25 ET | 11172 | 4.585 |
| 12:27 ET | 22878 | 4.58 |
| 12:30 ET | 1084 | 4.59 |
| 12:32 ET | 2112 | 4.59 |
| 12:34 ET | 400 | 4.59 |
| 12:36 ET | 218 | 4.58 |
| 12:38 ET | 3492 | 4.56 |
| 12:39 ET | 700 | 4.57 |
| 12:41 ET | 518 | 4.57 |
| 12:43 ET | 200 | 4.57 |
| 12:45 ET | 318 | 4.57 |
| 12:48 ET | 4429 | 4.55 |
| 12:50 ET | 100 | 4.54 |
| 12:52 ET | 3851 | 4.52 |
| 12:54 ET | 5848 | 4.54 |
| 12:56 ET | 3735 | 4.54 |
| 12:57 ET | 600 | 4.54 |
| 12:59 ET | 800 | 4.55 |
| 01:01 ET | 4800 | 4.545 |
| 01:03 ET | 1458 | 4.5412 |
| 01:06 ET | 100 | 4.54 |
| 01:10 ET | 700 | 4.54 |
| 01:12 ET | 1279 | 4.56 |
| 01:14 ET | 2019 | 4.55 |
| 01:15 ET | 3100 | 4.555 |
| 01:17 ET | 444 | 4.56 |
| 01:19 ET | 100 | 4.555 |
| 01:21 ET | 638 | 4.56 |
| 01:24 ET | 200 | 4.56 |
| 01:26 ET | 807 | 4.57 |
| 01:28 ET | 600 | 4.57 |
| 01:30 ET | 300 | 4.575 |
| 01:32 ET | 2072 | 4.56 |
| 01:33 ET | 644 | 4.559 |
| 01:37 ET | 11737 | 4.545 |
| 01:39 ET | 7809 | 4.55 |
| 01:42 ET | 558 | 4.555 |
| 01:44 ET | 500 | 4.56 |
| 01:46 ET | 700 | 4.555 |
| 01:48 ET | 100 | 4.555 |
| 01:50 ET | 500 | 4.565 |
| 01:51 ET | 1779 | 4.57 |
| 01:53 ET | 250 | 4.57 |
| 01:55 ET | 2413 | 4.575 |
| 01:57 ET | 1950 | 4.575 |
| 02:00 ET | 100 | 4.575 |
| 02:02 ET | 3292 | 4.57 |
| 02:04 ET | 100 | 4.56 |
| 02:06 ET | 100 | 4.56 |
| 02:08 ET | 300 | 4.56 |
| 02:09 ET | 500 | 4.555 |
| 02:11 ET | 200 | 4.555 |
| 02:13 ET | 300 | 4.555 |
| 02:15 ET | 5840 | 4.57 |
| 02:18 ET | 600 | 4.57 |
| 02:20 ET | 300 | 4.565 |
| 02:22 ET | 500 | 4.565 |
| 02:24 ET | 200 | 4.565 |
| 02:26 ET | 102 | 4.5688 |
| 02:27 ET | 297 | 4.565 |
| 02:29 ET | 2743 | 4.54 |
| 02:31 ET | 900 | 4.545 |
| 02:33 ET | 1670 | 4.55 |
| 02:36 ET | 422 | 4.54 |
| 02:38 ET | 680 | 4.54 |
| 02:42 ET | 400 | 4.545 |
| 02:44 ET | 1000 | 4.54 |
| 02:45 ET | 100 | 4.545 |
| 02:49 ET | 621 | 4.55 |
| 02:51 ET | 501 | 4.545 |
| 02:54 ET | 11341 | 4.55 |
| 02:56 ET | 1425 | 4.545 |
| 02:58 ET | 3151 | 4.545 |
| 03:00 ET | 6088 | 4.54 |
| 03:02 ET | 5657 | 4.54 |
| 03:03 ET | 2000 | 4.5407 |
| 03:05 ET | 2400 | 4.5401 |
| 03:07 ET | 300 | 4.54 |
| 03:09 ET | 6773 | 4.545 |
| 03:12 ET | 547 | 4.545 |
| 03:14 ET | 5744 | 4.54 |
| 03:16 ET | 615 | 4.545 |
| 03:18 ET | 501 | 4.55 |
| 03:20 ET | 2808 | 4.545 |
| 03:21 ET | 600 | 4.55 |
| 03:23 ET | 1897 | 4.549 |
| 03:25 ET | 1592 | 4.5499 |
| 03:27 ET | 9213 | 4.545 |
| 03:30 ET | 1600 | 4.545 |
| 03:32 ET | 500 | 4.55 |
| 03:34 ET | 3950 | 4.55 |
| 03:36 ET | 1700 | 4.55 |
| 03:38 ET | 2502 | 4.55 |
| 03:39 ET | 6172 | 4.54 |
| 03:41 ET | 2608 | 4.54 |
| 03:43 ET | 600 | 4.545 |
| 03:45 ET | 500 | 4.55 |
| 03:48 ET | 21787 | 4.535 |
| 03:50 ET | 2356 | 4.545 |
| 03:52 ET | 12048 | 4.54 |
| 03:54 ET | 1700 | 4.54 |
| 03:56 ET | 9425 | 4.545 |
| 03:57 ET | 20062 | 4.54 |
| 03:59 ET | 62909 | 4.54 |
Sep 23, 2024
DJ UniQure's Fabry Disease Treatment Gets Orphan Drug Designation from FDA, from 7:36AM ET on Monday Sep 23, 2024 by Dow Jones
7:36AM ET on Monday Sep 23, 2024 by Dow JonesuniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease, from 7:05AM ET on Monday Sep 23, 2024 by Dow Jones
7:05AM ET on Monday Sep 23, 2024 by Dow Jones
Sep 20, 2024
DJ uniQure Price Target Maintained With a $28.00/Share by Cantor Fitzgerald, from 12:36PM ET on Friday Sep 20, 2024 by Dow Jones
12:36PM ET on Friday Sep 20, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Uniqure NV | 221.1M | -0.8x | --- |
Molecular Partners AG | 176.4M | -2.2x | --- |
Mediwound Ltd | 181.4M | -7.8x | --- |
ProQR Therapeutics NV | 153.6M | -6.4x | --- |
Vaxart Inc | 196.1M | -1.8x | --- |
TScan Therapeutics Inc | 277.6M | -5.0x | --- |
Company Information
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.
Contact Information
- Headquarters
- Paasheuvelweg 25aAMSTERDAM, Netherlands 1105 BP
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- David Meek
- Chief Executive Officer, Executive Director
- Matthew Kapusta
- Chief Financial Officer
- Christian Klemt
- Chief Technical Operations Officer
- Amin Abujoub
- Chief Business and Scientific Officer
- Richard Porter
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $221.1M |
|---|---|
Revenue (TTM) | $27.7M |
Shares Outstanding | 48.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.93 |
EPS | $-5.92 |
Book Value | $4.34 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 8.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -872.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
